We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreNICE’s remodel plans focus on delivering faster and fairer access to treatments by optimising appr...
Read moreWith many anticipated new medicines for rare diseases, countries are beginning to prepare appropriat...
Read moreThe HST process is a method for evaluating medicines and treatments specifically indicated for ultra...
Read moreNICE’s Highly-Specialised Technologies (HST) process is a method for evaluating medicines and trea...
Read moreThe highly specialised technologies (HST) process was introduced in 2013 for the purpose of evaluati...
Read moreCell and gene therapies - life saving opportunity for many patients
Read moreThis resolution includes proposed reforms to the market access (including pricing) landscape designe...
Read moreThis study investigates costs of gene/acute therapies versus chronic treatments for rare diseases, o...
Read more